Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 21369 [2011-9123]

Download as PDF Federal Register / Vol. 76, No. 73 / Friday, April 15, 2011 / Notices environmental chemicals, physical substances, or mixtures (collectively referred to as ‘‘substances’’) cause adverse effects on reproduction and/or development and provide opinion on whether these substances are hazardous for humans. Information about CERHR can be obtained from its homepage (https://cerhr.niehs.nih.gov). Dated: April 7, 2011. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2011–9182 Filed 4–14–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: The Presidential Commission for the Study of Bioethical Issues will conduct its fifth meeting in May. At this meeting, the Commission will discuss the topic of Federal standards regarding human subjects protection in Federally funded scientific studies. DATES: The meeting will take place Wednesday, May 18, 2011, from 9 a.m. to approximately 4:45 p.m., and Thursday, May 19, 2011, from 9 a.m. to approximately 1:15 p.m. ADDRESSES: The Warwick New York Hotel, 65 West 54th Street, New York, NY 10019. Phone 212–247–2700. FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue, NW., Suite C–100, Washington, DC 20005. Telephone: 202–233–3963. E-mail: Hillary.Viers@bioethics.gov. Additional information may be obtained at https:// www.bioethics.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92–463, 5 U.S.C. app. 2, notice is hereby given of the fifth meeting of the Presidential Commission for the Study of Bioethical Issues (PCSBI). The meeting will be held from 9 a.m. to approximately 4:45 p.m. on Wednesday, May 18, 2011, and from 9 a.m. to approximately 1:15 p.m. on Thursday, May 19, 2011, at the Warwick New York Hotel, New York, NY. The srobinson on DSKHWCL6B1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:58 Apr 14, 2011 Jkt 223001 meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at https://www.bioethics.gov. Under authority of Executive Order 13521, dated November 24, 2009, the President established PCSBI to serve as a public forum and advise him on bioethical issues generated by novel and emerging research in biomedicine and related areas of science and technology. The Commission is charged to identify and promote policies and practices that assure ethically responsible conduct of scientific research, healthcare delivery, and technological innovation. In undertaking these duties, the Commission will examine specific bioethical, legal, and social issues related to potential scientific and technological advances; examine diverse perspectives and possibilities for useful international collaboration on these issues; and recommend legal, regulatory, or policy actions as appropriate. The main agenda item for this fifth meeting is to review Federal as well as transnational standards of human subjects protections in scientific studies supported by the Federal government as requested by President Obama on November 24, 2010. The draft meeting agenda and other information about PCSBI, including information about access to the webcast, will be available at https:// www.bioethics.gov. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. There will be a public comment session in the afternoon on May 18, 2011. Individuals who would like to provide public comment at that time should notify Esther Yoo by telephone at 202–233– 3960, or e-mail at Esther.Yoo@bioethics.gov before May 9, 2011. To accommodate as many speakers as possible the time for each individual to speak may be limited. If the number of individuals wishing to speak is greater than can reasonably be accommodated during the scheduled meeting, the Commission may randomly select speakers from among those who register to speak. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should also notify Esther Yoo (contact information above) in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Written comments will also be accepted and are especially welcome. Please address written comments by e- PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 21369 mail to info@bioethics.gov, or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Ave., NW, Suite C–100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Dated: April 6, 2011. Valerie H. Bonham, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2011–9123 Filed 4–14–11; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier CMS–10369] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: New collection; Title of Information Collection: Solicitation for Applications: Community-based Care Transitions Program; Use: The Community-based Care Transitions Program (CCTP) described in Section 3026 of the Affordable Care Act will run for 5 years with a mandated start date of January 1, 2011. This program provides funding to community-based organizations in partnership with acute care hospitals for the provision of care transition services delivered to high risk AGENCY: E:\FR\FM\15APN1.SGM 15APN1

Agencies

[Federal Register Volume 76, Number 73 (Friday, April 15, 2011)]
[Notices]
[Page 21369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9123]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
will conduct its fifth meeting in May. At this meeting, the Commission 
will discuss the topic of Federal standards regarding human subjects 
protection in Federally funded scientific studies.

DATES: The meeting will take place Wednesday, May 18, 2011, from 9 a.m. 
to approximately 4:45 p.m., and Thursday, May 19, 2011, from 9 a.m. to 
approximately 1:15 p.m.

ADDRESSES: The Warwick New York Hotel, 65 West 54th Street, New York, 
NY 10019. Phone 212-247-2700.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue, NW., Suite C-100, Washington, DC 20005. 
Telephone: 202-233-3963. E-mail: Hillary.Viers@bioethics.gov. 
Additional information may be obtained at https://www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the fifth meeting of the Presidential Commission for the Study of 
Bioethical Issues (PCSBI). The meeting will be held from 9 a.m. to 
approximately 4:45 p.m. on Wednesday, May 18, 2011, and from 9 a.m. to 
approximately 1:15 p.m. on Thursday, May 19, 2011, at the Warwick New 
York Hotel, New York, NY. The meeting will be open to the public with 
attendance limited to space available. The meeting will also be webcast 
at https://www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established PCSBI to serve as a public forum and advise 
him on bioethical issues generated by novel and emerging research in 
biomedicine and related areas of science and technology. The Commission 
is charged to identify and promote policies and practices that assure 
ethically responsible conduct of scientific research, healthcare 
delivery, and technological innovation. In undertaking these duties, 
the Commission will examine specific bioethical, legal, and social 
issues related to potential scientific and technological advances; 
examine diverse perspectives and possibilities for useful international 
collaboration on these issues; and recommend legal, regulatory, or 
policy actions as appropriate.
    The main agenda item for this fifth meeting is to review Federal as 
well as transnational standards of human subjects protections in 
scientific studies supported by the Federal government as requested by 
President Obama on November 24, 2010.
    The draft meeting agenda and other information about PCSBI, 
including information about access to the webcast, will be available at 
https://www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. There will be a public comment session 
in the afternoon on May 18, 2011. Individuals who would like to provide 
public comment at that time should notify Esther Yoo by telephone at 
202-233-3960, or e-mail at Esther.Yoo@bioethics.gov before May 9, 2011. 
To accommodate as many speakers as possible the time for each 
individual to speak may be limited. If the number of individuals 
wishing to speak is greater than can reasonably be accommodated during 
the scheduled meeting, the Commission may randomly select speakers from 
among those who register to speak.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should also notify Esther Yoo (contact information 
above) in advance of the meeting. The Commission will make every effort 
to accommodate persons who need special assistance.
    Written comments will also be accepted and are especially welcome. 
Please address written comments by e-mail to info@bioethics.gov, or by 
mail to the following address: Public Commentary, Presidential 
Commission for the Study of Bioethical Issues, 1425 New York Ave., NW, 
Suite C-100, Washington, DC 20005. Comments will be publicly available, 
including any personally identifiable or confidential business 
information that they contain. Trade secrets should not be submitted.

    Dated: April 6, 2011.
Valerie H. Bonham,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2011-9123 Filed 4-14-11; 8:45 am]
BILLING CODE 4154-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.